WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
About 30% of S&P 500 companies are slated to report earnings in the coming week, according to FactSet. Two Dow...
The proposed settlement is the latest move by a company seeking to resolve the costly litigation. Under the terms, the...
The Centers for Disease Control and Prevention on Tuesday recommended the use of Novavax Inc.’s Covid-19 vaccine, the final hurdle...
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s...
Abbott Laboratories ABT -0.21% has reopened its biggest factory after a shutdown last month that dealt another blow to efforts...
Walgreens Boots Alliance Inc. is bracing for a recession and life after Covid. The second-biggest U.S. drugstore chain by stores...
Some of the nation’s biggest retailers are rationing over-the-counter emergency contraceptive pills as demand spikes following the Supreme Court ruling...
Pfizer Inc. and BioNTech SE vaccines modified to target the Omicron variant produced a significantly larger immune response than the...
Canada approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal...
The Supreme Court on Tuesday declined to hear a bid by Bayer AG to end thousands of lawsuits alleging its...
Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with...
A positive recommendation would likely lead soon to expanding the U.S. Covid-19 vaccination campaign to the 19.6 million children 6...
The FDA staff also said, in a review of study data posted online Sunday, that there were no new safety...
John Arnold antagonized public-employee unions and pharmaceutical firms with campaigns to reform government-funded pensions and bring down high drug prices....
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
New data suggest that the U.S. baby-formula shortage is deepening, particularly hitting states in the South and the Southwest. Nationally,...
U.S. health regulators took steps to allow more foreign baby formula on American shelves, easing rules that had effectively prevented...
WASHINGTON—The House Oversight Committee has launched an investigation into the four major manufacturers of baby formula, including the makers of...
Baby-formula manufacturers and retailers say they are working to address a long-running shortage in products on store shelves, but the...